Loss of EZH2 can induce down-regulation of BRAC1 that in turn triggers reprogramming capability, resulting in significantly increased tumor sphere formation, Levels of ALDH, and express stem cells phenotype in prostate cancer cells (51). This evidence concerns the gene EZH2 and prostate cancer.